DHP phase II proposal H2-0159 entitled, "optimal rewarming solutions for cryopreserved tissue systems: rapid rewarming reduction of cryoprotectant toxicity and concentration employing magnetic…
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH16C0074
- Awardee
-
Tissue Testing Technologies LLC UEI ZSY2J1RRALT5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $938,442
Award facts
- Opportunity
-
- HQ003415R1DSB Solicitation number
- Contract value 100% obligated
- $938,441.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Fixed Price Level of Effort
- Place of performance
- North Charleston, SC 29406, USA
- Research
- SBIR Program Phase III Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$11,292 | |
| Supplemental Agreement for work within scope | -$44,692 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Original award | $994,426 |
About this award
This is a Small Business Innovation Research (SBIR) Phase III contract award from the Department of the Army Medical Command (MEDCOM) to Tissue Testing Technologies LLC, a small disadvantaged business. The $938,441.90 fixed-price level of effort contract is for the further development and optimization of rapid rewarming and cryoprotectant toxicity reduction techniques using magnetic nanoparticles, building on the company's prior SBIR Phase I and II research. The goal is to improve the cryopreservation and banking of tissues and organs for transplantation, trauma care, and regenerative medicine applications. This award expands on Tissue Testing Technologies' expertise in ice-free vitrification and hypothermic storage solutions for a range of tissues developed through past grants from the National Institutes of Health and the Army MEDCOM.
Description
DHP phase II proposal H2-0159 entitled, "optimal rewarming solutions for cryopreserved tissue systems: rapid rewarming reduction of cryoprotectant toxicity and concentration employing magnetic nanoparticles."
Quick answers
Who was awarded contract W81XWH16C0074?
W81XWH16C0074 was awarded to Tissue Testing Technologies LLC by Medical Command (Department of the Army) on September 15, 2016.
How much is contract W81XWH16C0074 worth?
The government has obligated $938,442 on W81XWH16C0074.
Was contract W81XWH16C0074 competed?
The extent of competition for W81XWH16C0074 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award